Find a Physician | Courier | Events Calendar | About Us | Clinical Trials

Lurie Cancer Center at the 2017 ASCO Annual Meeting

ASCO Annual Meeting

Oncology Review

Lynn Sage Breast Cancer Symposium

Learn more about research and shared resources at the Lurie Cancer Center, and take advantage of upcoming professional education programs.

More than 30,000 oncology professionals from around the world will gather at McCormick Place from June 2 - 6 to learn, share, discuss and debate practice-changing discoveries in cancer care at the 2017 American Society of Clinical Oncology's (ASCO) Annual Meeting in Chicago.

Visit us at booth #4036 in the ASCO Oncology Professionals Hall.

Lurie Cancer Center Faculty Present Leading-Edge Research

Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present oral abstracts or posters, lead discussions about new research or chair sessions at this year’s ASCO Annual Meeting. Lead authors from the Lurie Cancer Center presenting abstracts include:

Jessica Altman, MD Jessica Altman, MD
Deep molecular response to gilteritinib to improve survival in FLT3 mutation-positive relapsed/refractory acute myeloid leukemia.
Abstract #7003
Jason Fangusaro, MD Jason Fangusaro, MD
A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study.
Abstract #10504
William Gradishar, MD William Gradishar, MD
Phase III study of lapatinib (L) plus trastuzumab (T) and aromatase inhibitor (AI) vs T+AI vs L+AI in postmenopausal women (PMW) with HER2+, HR+ metastatic breast cancer (MBC): ALTERNATIVE.
Abstract #1004
Maha Hussain, MD Maha Hussain, MD
Abiraterone + prednisone +/- veliparib for patients with metastatic castration-resistant prostate cancer: NCI 9012 updated clinical and genomics data.
Abstract #5001
Daniela Matei, MD Daniela Matei, MD
A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma
Abstract #5505

Check out ASCO’s iPlanner for the 2017 schedule, dates and recommended sessions based on your interests. View the Annual Meeting Abstracts here.

Expert Interviews

Experts from the Lurie Cancer Center are available to comment on a wide range of topics on site during the ASCO meeting, as well as by telephone or email.  For more information or to schedule interviews, please email Jennifer Bowker at

Lurie Cancer Center Clinical Trials

Search Clinical Trials

Access on your phone or tablet for convenient access to our catalog of clinical trials. No download neccessary; compatable with Apple, Android and Microsoft portable devices.